ACSS1 and Miyoshi myopathy: Interestingly, in a subset of MM patients, AceCS1/2 expression is increased, while levels of ACL and PDH are reduced, indicating a preferential use of acetate as a source of acetyl moieties and pointing towards a possible therapeutic vulnerability [245].